Experts say IBCs are a crucial tool for ensuring the safety of biomedical research. But evidence suggests that IBC oversight still varies from institution to institution, creating a biosafety system that’s uneven, fiercely resistant to public scrutiny, and subject to minimal enforcement from the NIH.
↧